Published in Neurology on March 11, 2008
Genetic and Physical Characteristics of Rett Syndrome | NCT00299312
Treatment of Rett Syndrome With Recombinant Human IGF-1 | NCT01777542
Natural History of Rett Syndrome & Related Disorders | NCT02738281
Biobanking of Rett Syndrome and Related Disorders | NCT02705677
Rare Diseases Clinical Research Network: Neurophysiological Correlates | NCT03077308
MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell (2012) 4.56
Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities. Proc Natl Acad Sci U S A (2009) 1.79
Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome. J Med Genet (2014) 1.58
Psychotropic medication use among children with autism spectrum disorders enrolled in a national registry, 2007-2008. J Autism Dev Disord (2010) 1.46
The genetic basis of non-syndromic intellectual disability: a review. J Neurodev Disord (2010) 1.45
Rett syndrome diagnostic criteria: lessons from the Natural History Study. Ann Neurol (2010) 1.33
Experimental models of Rett syndrome based on Mecp2 dysfunction. Exp Biol Med (Maywood) (2011) 1.27
Linking MECP2 and pain sensitivity: the example of Rett syndrome. Am J Med Genet A (2010) 1.19
The CDKL5 disorder is an independent clinical entity associated with early-onset encephalopathy. Eur J Hum Genet (2012) 1.17
Trends in the diagnosis of Rett syndrome in Australia. Pediatr Res (2011) 1.09
Revealing the complexity of a monogenic disease: rett syndrome exome sequencing. PLoS One (2013) 1.02
BDNF deregulation in Rett syndrome. Neuropharmacology (2013) 1.02
Linking epigenetics to human disease and Rett syndrome: the emerging novel and challenging concepts in MeCP2 research. Neural Plast (2012) 1.02
Assessment and management of nutrition and growth in Rett syndrome. J Pediatr Gastroenterol Nutr (2013) 1.00
Updating the profile of C-terminal MECP2 deletions in Rett syndrome. J Med Genet (2009) 0.99
The common BDNF polymorphism may be a modifier of disease severity in Rett syndrome. Neurology (2009) 0.97
Clinical and biological progress over 50 years in Rett syndrome. Nat Rev Neurol (2016) 0.95
Developmental delay in Rett syndrome: data from the natural history study. J Neurodev Disord (2014) 0.95
InterRett, a model for international data collection in a rare genetic disorder. Res Autism Spectr Disord (2009) 0.92
Brain metabolism in Rett syndrome: age, clinical, and genotype correlations. Ann Neurol (2009) 0.92
The phenotype associated with a large deletion on MECP2. Eur J Hum Genet (2012) 0.91
A novel hypomorphic MECP2 point mutation is associated with a neuropsychiatric phenotype. Hum Genet (2008) 0.90
Parent report of community psychiatric comorbid diagnoses in autism spectrum disorders. Autism Res Treat (2011) 0.90
Twenty years of surveillance in Rett syndrome: what does this tell us? Orphanet J Rare Dis (2014) 0.87
Profiling early socio-communicative development in five young girls with the preserved speech variant of Rett syndrome. Res Dev Disabil (2012) 0.86
Computational and experimental approaches to reveal the effects of single nucleotide polymorphisms with respect to disease diagnostics. Int J Mol Sci (2014) 0.86
Level of purposeful hand function as a marker of clinical severity in Rett syndrome. Dev Med Child Neurol (2010) 0.86
Respiratory phenotypes are distinctly affected in mice with common Rett syndrome mutations MeCP2 T158A and R168X. Neuroscience (2014) 0.86
Atypical presentations and specific genotypes are associated with a delay in diagnosis in females with Rett syndrome. Am J Med Genet A (2010) 0.86
Rett Syndrome: Reaching for Clinical Trials. Neurotherapeutics (2015) 0.85
The association between child autism symptomatology, maternal quality of life, and risk for depression. J Autism Dev Disord (2013) 0.85
A study of the treatment of Rett syndrome with folate and betaine. J Child Neurol (2009) 0.84
Management of epilepsy in patients with Rett syndrome: perspectives and considerations. Ther Clin Risk Manag (2015) 0.84
Validating the Rett Syndrome Gross Motor Scale. PLoS One (2016) 0.83
Clinical Guidelines for Management of Bone Health in Rett Syndrome Based on Expert Consensus and Available Evidence. PLoS One (2016) 0.82
Experience of gastrostomy using a quality care framework: the example of rett syndrome. Medicine (Baltimore) (2014) 0.82
5-Hydroxymethylcytosine: A new player in brain disorders? Exp Neurol (2014) 0.82
The trajectories of sleep disturbances in Rett syndrome. J Sleep Res (2014) 0.82
There is variability in the attainment of developmental milestones in the CDKL5 disorder. J Neurodev Disord (2015) 0.82
The relationship between MECP2 mutation type and health status and service use trajectories over time in a Rett syndrome population. Res Autism Spectr Disord (2011) 0.81
Variable phenotypic expression of a MECP2 mutation in a family. J Neurodev Disord (2009) 0.81
Brief report: MECP2 mutations in people without Rett syndrome. J Autism Dev Disord (2014) 0.79
Genetics and neuropsychiatric disorders: genome-wide, yet narrow. Nat Med (2009) 0.79
Genes related to mitochondrial functions, protein degradation, and chromatin folding are differentially expressed in lymphomonocytes of Rett syndrome patients. Mediators Inflamm (2013) 0.79
MECP2 Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in Malignancy. Cancer Discov (2015) 0.79
Mood disorders in mothers of children on the autism spectrum are associated with higher functioning autism. Autism Res Treat (2012) 0.78
Neurophysiology versus clinical genetics in Rett syndrome: A multicenter study. Am J Med Genet A (2016) 0.78
Correlation of the vesicular acetylcholine transporter densities in the striata to the clinical abilities of women with Rett syndrome. Synapse (2012) 0.78
Two new Rett syndrome families and review of the literature: expanding the knowledge of MECP2 frameshift mutations. Orphanet J Rare Dis (2011) 0.78
Anxiety-like behavior in Rett syndrome: characteristics and assessment by anxiety scales. J Neurodev Disord (2015) 0.77
Neurobiologically-based treatments in Rett syndrome: opportunities and challenges. Expert Opin Orphan Drugs (2016) 0.76
Pubertal development in Rett syndrome deviates from typical females. Pediatr Neurol (2014) 0.76
Apoptotic Activity of MeCP2 Is Enhanced by C-Terminal Truncating Mutations. PLoS One (2016) 0.75
Autonomic breathing abnormalities in Rett syndrome: caregiver perspectives in an international database study. J Neurodev Disord (2017) 0.75
Rett syndrome: a wide clinical and autonomic picture. Orphanet J Rare Dis (2016) 0.75
Progress in Rett Syndrome: from discovery to clinical trials. Wien Med Wochenschr (2016) 0.75
MECP2 mutations in Czech patients with Rett syndrome and Rett-like phenotypes: novel mutations, genotype-phenotype correlations and validation of high-resolution melting analysis for mutation scanning. J Hum Genet (2016) 0.75
Functional outcomes in Rett syndrome. Brain Dev (2015) 0.75
Karyopherin α 3 and karyopherin α 4 proteins mediate the nuclear import of methyl-CpG binding protein 2. J Biol Chem (2015) 0.75
A plasma proteomic approach in Rett syndrome: classical versus preserved speech variant. Mediators Inflamm (2013) 0.75
How can clinical ethics guide the management of comorbidities in the child with Rett syndrome? J Paediatr Child Health (2016) 0.75
Quantitative and qualitative insights into the experiences of children with Rett syndrome and their families. Wien Med Wochenschr (2016) 0.75
The utility of Next Generation Sequencing for molecular diagnostics in Rett syndrome. Sci Rep (2017) 0.75
Spectrophotometric quantitation of antioxidant capacity through the formation of a phosphomolybdenum complex: specific application to the determination of vitamin E. Anal Biochem (1999) 8.50
Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science (1997) 6.10
Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites. Neuron (1995) 5.43
Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome. Neurology (2008) 3.74
Broad-spectrum resistance to Bacillus thuringiensis toxins in Heliothis virescens. Proc Natl Acad Sci U S A (1992) 3.73
Diffusion tensor imaging and axonal tracking in the human brainstem. Neuroimage (2001) 3.58
Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group. Lancet (1999) 3.32
Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron (1993) 3.30
Scotland's health--a more difficult challenge for some? The price and availability of healthy foods in socially contrasting localities in the west of Scotland. Health Bull (Edinb) (1993) 3.24
Does area of residence affect body size and shape? Int J Obes Relat Metab Disord (1997) 2.83
Histological grading of breast carcinomas: a study of interobserver agreement. Hum Pathol (1995) 2.63
Development of a suspicion index to aid diagnosis of Niemann-Pick disease type C. Neurology (2012) 2.53
Recognition of facial emotion in nine individuals with bilateral amygdala damage. Neuropsychologia (1999) 2.42
An immunoepidemiological approach to asthma: identification of in-vitro T-cell response patterns associated with different wheezing phenotypes in children. Lancet (2005) 2.39
A psychometric experiment in causal inference to estimate evidential weights used by epidemiologists. Epidemiology (2001) 2.30
rheb, a growth factor- and synaptic activity-regulated gene, encodes a novel Ras-related protein. J Biol Chem (1994) 2.25
Diffusion tensor imaging of the developing mouse brain. Magn Reson Med (2001) 2.20
Nevoid basal cell carcinoma syndrome: review of 118 affected individuals. Am J Med Genet (1994) 2.06
Changes in risk factors for preterm birth in Western Australia 1984-2006. BJOG (2013) 2.06
Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene. Am J Hum Genet (1997) 2.06
Initial frequency of alleles for resistance to Bacillus thuringiensis toxins in field populations of Heliothis virescens. Proc Natl Acad Sci U S A (1997) 2.03
Neuronal sodium-channel alpha1-subunit mutations in generalized epilepsy with febrile seizures plus. Am J Hum Genet (2001) 2.01
Chromosome 4 localization of a second gene for autosomal dominant polycystic kidney disease. Nat Genet (1993) 2.01
Cost of services at neighborhood health centers. A comparative analysis. N Engl J Med (1972) 2.00
Guidelines for reporting clinical features in cases with MECP2 mutations. Brain Dev (2001) 1.99
Staffing at veterinary schools. Vet Rec (1998) 1.94
Reliability and validity of MRI measurement of the amygdala and hippocampus in children with fragile X syndrome. Psychiatry Res (1997) 1.85
Sensitivity of the Diagnostic Interview Schedule for Children, 2nd edition (DISC-2.1) for specific diagnoses of children and adolescents. J Am Acad Child Adolesc Psychiatry (1993) 1.83
Saying what you mean in dialogue: a study in conceptual and semantic co-ordination. Cognition (1987) 1.82
Antitoxic immunity in experimental cholera: protection, and serum and local antibody responses in rabbits after enteral and parenteral immunization. Infect Immun (1975) 1.82
The formation and catabolism of methylglyoxal during glycolysis in Escherichia coli. FEBS Lett (1970) 1.74
Familial phenotype differences in PKD11. Kidney Int (1999) 1.72
Pharmacokinetics of the H2- receptor antagonist ranitidine in man. Br J Clin Pharmacol (1981) 1.67
Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (bo,+AT) of rBAT. Nat Genet (1999) 1.65
Identification of SLC7A7, encoding y+LAT-1, as the lysinuric protein intolerance gene. Nat Genet (1999) 1.65
The effect of genotype on the natural history of eIF2B-related leukodystrophies. Neurology (2004) 1.63
Obsessive-compulsive disorder in children and adolescents. Clinical phenomenology of 70 consecutive cases. Arch Gen Psychiatry (1989) 1.62
Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location. Hum Mol Genet (2000) 1.61
Gene expression profiling in postmortem Rett Syndrome brain: differential gene expression and patient classification. Neurobiol Dis (2001) 1.59
Niemann-Pick C disease in Spain: clinical spectrum and development of a disability scale. J Neurol Sci (2006) 1.58
Genetic mapping of a locus for triosephosphate isomerase on the genome of Escherichia coli K12. J Gen Microbiol (1970) 1.56
Effect of indomethacin on blood pressure in elderly people with essential hypertension well controlled on amlodipine or enalapril. Am J Hypertens (2000) 1.55
Familial Dandy-Walker malformation associated with macrocephaly, facial anomalies, developmental delay, and brain stem dysgenesis: prenatal diagnosis and postnatal outcome in brothers. A new syndrome? Am J Med Genet (1994) 1.54
Histone deacetylase inhibitors trigger a G2 checkpoint in normal cells that is defective in tumor cells. Mol Biol Cell (2000) 1.54
An emerging role for galectins in tuning the immune response: lessons from experimental models of inflammatory disease, autoimmunity and cancer. Scand J Immunol (2007) 1.53
Factors affecting gestational age at therapeutic abortion. Lancet (1972) 1.53
Age-dependent cognitive deficits and neuronal apoptosis in cyclooxygenase-2 transgenic mice. J Neurosci (2001) 1.53
HFE mutations, iron deficiency and overload in 10,500 blood donors. Br J Haematol (2001) 1.52
The effect on 24 h blood pressure control of an angiotensin converting enzyme inhibitor (perindopril) administered in the morning or at night. J Hypertens (1997) 1.51
Automated Talairach atlas-based parcellation and measurement of cerebral lobes in children. Psychiatry Res (1999) 1.51
Identification and characterization of a membrane protein (y+L amino acid transporter-1) that associates with 4F2hc to encode the amino acid transport activity y+L. A candidate gene for lysinuric protein intolerance. J Biol Chem (1998) 1.50
The additional risk of malignant mesothelioma in former workers and residents of Wittenoom with benign pleural disease or asbestosis. Occup Environ Med (2005) 1.47
Regional cortical white matter reductions in velocardiofacial syndrome: a volumetric MRI analysis. Biol Psychiatry (2001) 1.46
Early progressive encephalopathy in boys and MECP2 mutations. Neurology (2006) 1.44
Women with intellectual disability who have offended: characteristics and outcome. J Intellect Disabil Res (2004) 1.42
Proline in alpha-helix: stability and conformation studied by dynamics simulation. Proteins (1991) 1.39
Pulse oximetry or pulse photometry. Anaesth Intensive Care (1991) 1.39
Assessing the value of employee training. Health Care Manage Rev (1988) 1.39
Molecular biology. U.S. juggernaut overwhelms divided European elite. Science (1992) 1.39
Plagiarism charge casts shadow on peer review. Nature (1989) 1.39
In vivo visualization of human neural pathways by magnetic resonance imaging. Ann Neurol (2000) 1.37
Role of two upstream open reading frames in the translational control of oncogene mdm2. Oncogene (1999) 1.37
Homozygosity mapping of Hallervorden-Spatz syndrome to chromosome 20p12.3-p13. Nat Genet (1996) 1.36
Utilization and cost experience of low-income families in four prepaid group-practice plans. N Engl J Med (1973) 1.33
Describing the phenotype in Rett syndrome using a population database. Arch Dis Child (2003) 1.33
Long-term prognosis after recovery from myocardial infarction: a nine year follow-up of the Perth Coronary Register. Circulation (1983) 1.33
Hepatitis B knowledge among Vietnamese immigrants: implications for prevention of hepatocellular carcinoma. J Cancer Educ (2000) 1.32
Assessing autonomic dysfunction in early diabetic neuropathy: the Survey of Autonomic Symptoms. Neurology (2011) 1.32
Trends in mode of delivery during 1984-2003: can they be explained by pregnancy and delivery complications? BJOG (2007) 1.31
Developmental dyslexia in women: neuropathological findings in three patients. Ann Neurol (1990) 1.30
Pseudobacteremia caused by Clostridium sordellii. Arch Intern Med (1980) 1.29
Patients with the R133C mutation: is their phenotype different from patients with Rett syndrome with other mutations? J Med Genet (2003) 1.28
Diets for disease? Intraurban variation in reported food consumption in Glasgow. Appetite (1994) 1.27
Rett syndrome in Spain: mutation analysis and clinical correlations. Brain Dev (2001) 1.26
Gross rearrangements of the MECP2 gene are found in both classical and atypical Rett syndrome patients. J Med Genet (2005) 1.26
Nosocomial transmission of Mycobacterium tuberculosis: role of health care workers in outbreak propagation. J Infect Dis (1995) 1.24
Oncological safety and patient satisfaction with skin-sparing mastectomy and immediate breast reconstruction. Surg Oncol (2008) 1.23
Refining the phenotype of common mutations in Rett syndrome. J Med Genet (2004) 1.22
Indole-3-carbinol prevents cervical cancer in human papilloma virus type 16 (HPV16) transgenic mice. Cancer Res (1999) 1.21
Structural principles that govern the peptide-binding motifs of class I MHC molecules. J Mol Biol (1998) 1.20
Novel FOXG1 mutations associated with the congenital variant of Rett syndrome. J Med Genet (2009) 1.19
Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern. Neuroscience (2006) 1.15
Alcoholic drinks: important triggers for asthma. J Allergy Clin Immunol (2000) 1.14
Localization of a phenobarbital-responsive element (PBRE) in the 5'-flanking region of the rat CYP2B2 gene. Gene (1995) 1.14
Rare childhood diseases: how should we respond? Arch Dis Child (2008) 1.14
Impact of standardised feeding regimens on incidence of neonatal necrotising enterocolitis: a systematic review and meta-analysis of observational studies. Arch Dis Child Fetal Neonatal Ed (2005) 1.14
Rapid suppression of alpha 1-fetoprotein gene transcription by dexamethasone in developing rat liver. Biochemistry (1983) 1.13
Individual versus job-based health insurance: weighing the pros and cons. Health Aff (Millwood) (2000) 1.13
Excess free energy of liquids from molecular dynamics simulations. Application to water models. J Am Chem Soc (1988) 1.13
Survival of infants born with Down's syndrome: 1980-96. Paediatr Perinat Epidemiol (2000) 1.12
Smokeless tobacco brand switching: a means to reduce toxicant exposure? Drug Alcohol Depend (2006) 1.12